2m 2m 2m 2m 2m 2m 2m
Q32 BIO (QTTB)
NASDAQ
$11.11+$0.005 (+0.05%)
Price as of Sep 11, 2026 7:30 PM EDT- $330.4MMarket Cap
- 475.13%1-Year Change
- BiotechnologyIndustry
Q32 BIO (QTTB)
$11.11+$0.005 (+0.05%)
QTTB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.10 | ||
Change | +$0.38 (+3.54%) | ||
Open | $10.82 | ||
High | $11.27 | ||
Low | $10.45 | ||
Previous Close | $10.72 | ||
Volume | 1,824,470 | ||
30-Day Average Volume | 493,740 | ||
1-Week Change | -7.42% | ||
1-Month Change | -27.97% | ||
1-Year Change | 475.13% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 29.8M | ||
Total Assets | $115.9M | ||
Market Cap | $330.4M | ||
Enterprise Value | $224.2M | ||
Period: QTR TTM FY | |||
Revenue | -$246,000.00 | ||
Net Income | -$8.9M | ||
Free Cash Flow | -$3.1M | ||
EBIT | -$8.7M | ||
EBITDA | -$8.7M | ||
Net Working Capital | $104.2M | ||
EPS | -$0.44 | ||
Enterprise Value/EBITDA | -26 | ||
Enterprise Value/Revenue | -911 | ||
P/B | 3 | ||
P/E | -25 | ||
PEG | -1 | ||
Price/Free Cash Flow | -107 | ||
Price/Operating Cash Flow | -107 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue